GSK employee vaccination: Caring begins at home

For GlaxoSmithKline, improving health and quality of life begins at home.

GSK has been on the forefront of the advocacy to promote vaccination as the first line of defense against diseases, and it walks its talk with its internal audience – the company employees themselves – as well as the general public.

Recently, GSK proved this anew as it dedicated a whole day to vaccinate its female employees against cervical cancer. About 200 employees initially availed of the vaccine and the number is expected to double as the company rolls out the vaccination to reach its employees nationwide.

The employee vaccination is an annual internal CSR program of GSK for its employees. The inclusion of cervical cancer vaccination in this year's program comes at a most appropriate time as GSK has just launched a cervical cancer vaccine that is approved not only for the young but for older women as well to protect them from the second deadliest disease that claims the most lives among of a lot of Filipino women every year.

Celebrities who came to express support to GSK’s vaccination advocacy include fashion icon Tessa Prieto-Valdes, model Abbygale Arenas-de Leon, TV host Ruby Rodriguez, beauty queen Miriam Quiambao, actress Mymy Davao, dermatologist Vicki Belo, and respected journalist Rina Jimenez-David.

Also on hand to witness the activity were Dr. Eric Tayag, President of the Philippine Foundation for Vaccination, Dr Roger Mendiola, President of the Philippine Obstetrics and Gynecology Society, Dr Rey delos Reyes of the Society of Gynecologic and Oncologists of the Philippines, Dr. Cecile Llave of the Cervical Cancer Prevention Network of the UP-PGH and Drs. Leoncia Olonan and Emma Llanto of the Society of Adolescent Medicine of the Philippines, Inc.



^ Back to top
Philippines

GSK at a glance

We are the only pharmaceutical company to tackle the three "priority" diseases identified by the World Health Organization: HIV/AIDS, tuberculosis and malaria
Our business employs over 100,000 people in 117 countries
We make almost four billion packs of medicines and healthcare products every year
We screen about 65 million compounds every year in our search for new medicines
We supply one quarter of the world's vaccines and by the end of 2007 we had 23 vaccines in clinical development
To date, we have donated over 750 million albendazole tablets to help elimitate lymphatic filariasis (elephantiasis) in the world
In 2006 we shipped 126 million tablets of preferentially-priced Combivir and Epivir (our HIV treatments) to developing countries
Almost 100 countries benefitted from our humanitarian product donations